Cantargia

0 Followers

About

Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.

Göran Forsberg
Collapse
Liselotte Larsson
VP Operations
David Liberg
VP Cancer Research
Lars Thorsson
VP Clinical Development
Nedjad Losic
VP Biometrics
Susanne Lagerlund
VP Regulatory Affairs

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.